A Real-World Study of Prognostic Factors and Risk-Stratification Model from Taiwanese Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Cetuximab Containing Regimen.
Journal of clinical oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要